Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2146513
Max Phase: Preclinical
Molecular Formula: C27H42N4O2S2
Molecular Weight: 518.79
Molecule Type: Small molecule
Associated Items:
ID: ALA2146513
Max Phase: Preclinical
Molecular Formula: C27H42N4O2S2
Molecular Weight: 518.79
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCN(CC[C@H]1CC[C@H](NS(=O)(=O)c2ccc(C(C)C)cc2)CC1)[C@H]1CCc2nc(N)sc2C1
Standard InChI: InChI=1S/C27H42N4O2S2/c1-4-16-31(23-11-14-25-26(18-23)34-27(28)29-25)17-15-20-5-9-22(10-6-20)30-35(32,33)24-12-7-21(8-13-24)19(2)3/h7-8,12-13,19-20,22-23,30H,4-6,9-11,14-18H2,1-3H3,(H2,28,29)/t20-,22-,23-/m0/s1
Standard InChI Key: LIQHEVUUUUUOCC-PMVMPFDFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 518.79 | Molecular Weight (Monoisotopic): 518.2749 | AlogP: 5.35 | #Rotatable Bonds: 10 |
Polar Surface Area: 88.32 | Molecular Species: BASE | HBA: 6 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 10.18 | CX Basic pKa: 10.84 | CX LogP: 5.11 | CX LogD: 2.77 |
Aromatic Rings: 2 | Heavy Atoms: 35 | QED Weighted: 0.44 | Np Likeness Score: -1.45 |
1. Chen J, Levant B, Wang S.. (2012) High-affinity and selective dopamine D₃ receptor full agonists., 22 (17): [PMID:22871578] [10.1016/j.bmcl.2012.07.003] |
Source(1):